MeMed BV clinical evidence

24 Apr 2026

This resource summarizes the clinical and real‑world evidence supporting MeMed BV®, a host‑response diagnostic that differentiates bacterial from viral infections in adult patients. Drawing on data from more than 20 clinical studies and over 20,000 enrolled patients across the United States, Europe, and Israel, the evidence demonstrates that MeMed BV® can reduce unnecessary antibiotic use, support appropriate prescribing decisions, and maintain patient safety across emergency department and urgent care settings.

Links

Tags

Antimicrobial Resistance (AMR)Respiratory InfectionsRespiratory infections are caused by pathogens such as bacteria, viruses, and fungi, leading to diseases like pneumonia, tuberculosis, and COVID-19. It is important to identify respiratory infections quickly in patients to ensure appropriate treatment and care, and to prevent sepsis. Browse our peer-reviewed product directory to find the best tools for respiratory infection detection, compare products, check reviews, and get pricing directly from manufacturers.Diagnostics
Memed BV clinical evidence on infection diagnosis - SelectScience resources